5-Azacytidine facilitates osteogenic gene expression and differentiation of mesenchymal stem cells by alteration in DNA methylation
- 26 June 2009
- journal article
- research article
- Published by Springer Nature in Cytotechnology
- Vol. 60 (1-3) , 11-22
Abstract
Mesenchymal stem cells (MSCs) are considered to be one of the most promising therapeutic cell sources as they encompass a plasticity of multiple cell lineages. The challenge in using these cells lies in developing well-defined protocols for directing cellular differentiation to generate a desired lineage. In this study, we investigated the effect of 5-azacytidine, a DNA demethylating agent, on osteogenic differentiation of MSCs. The cells were exposed to 5-azacytidine in culture medium for 24 h prior to osteogenic induction. Osteogenic differentiation was determined by several the appearance of a number of osteogenesis characteristics, including gene expression, ALP activity, and calcium mineralization. Pretreatment of MSCs with 5-azacytidine significantly facilitated osteogenic differentiation and was accompanied by hypomethylation of genomic DNA and increased osteogenic gene expression. Taking dlx5 as a representative, methylation alterations of the “CpG island shore” in the promoter caused by 5-azacytidine appeared to contribute to osteogenic differentiation.Keywords
This publication has 33 references indexed in Scilit:
- Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical ImplicationsPLOS ONE, 2009
- The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shoresNature Genetics, 2009
- CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patientsBritish Journal of Cancer, 2009
- Promoter CpG Methylation Contributes to ES Cell Gene Regulation in Parallel with Oct4/Nanog, PcG Complex, and Histone H3 K4/K27 TrimethylationCell Stem Cell, 2008
- Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cellsBiochemical and Biophysical Research Communications, 2007
- Cell-Based Bone Tissue EngineeringPLOS Medicine, 2007
- Inhibition of Histone Deacetylation Does Not Block Resilencing of p16 after 5-Aza-2′-Deoxycytidine TreatmentCancer Research, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- CpG island methylator phenotype in cancerNature Reviews Cancer, 2004
- A rapid technique for alkaline phosphatase enzyme activity in tissuesActa Histochemica, 1983